Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
TVM Capital Healthcare Opens New Office in Riyadh, Saudi Arabia
TVM Capital Healthcare, a global specialist healthcare private equity firm operating in emerging markets, announced […]
Innovent Receives NMPA Breakthrough Designation for IBI351 (KRASG12C Inhibitor) as Monotherapy for Previously Treated Advanced Colorectal Carcinoma
Innovent Biologics, a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the […]
Numab Therapeutics Announces First Subject Dosed in Phase 1 Clinical Study of Atopic Dermatitis Treatment
Numab Therapeutics AG (Numab), a clinical-stage biotechnology company advancing a proprietary pipeline of immunology and […]
Sarepta Therapeutics Announces Positive Vote from FDA Advisory Committee Meeting for SRP-9001 Gene Therapy to Treat Duchenne Muscular Dystrophy
Sarepta Therapeutics, the leader in precision genetic medicine for rare diseases, today announced that the […]
LaNova Medicines Announces Global Exclusive License Agreement with AstraZeneca for LM-305, a Novel GPRC5D-Targeting Antibody Drug Conjugate
LaNova Medicines has announced it has entered into an exclusive license agreement with AstraZeneca, for […]
NeuroBo Pharmaceuticals Appoints Pharmaceutical Industry Executive, Mark A. Glickman, to its Board of Directors
NeuroBo Pharmaceuticals, a clinical-stage biotechnology company on a quest to transform cardiometabolic diseases, today announced […]
Rona Therapeutics and Keymed Biosciences Announce Collaboration to Discover and Develop First-in-class siRNA Therapeutics for Glomerulonephritis
Rona Therapeutics and Keymed Biosciences announced a collaboration to jointly discover and develop first-in-class siRNA […]
PTP Announces Partnership with TetraScience to Accelerate Innovation in Therapeutics
PTP, a leading cloud consultancy firm specializing in the life sciences industry, is pleased to […]
Michael Corley, BSAC, on Partnerships Within the Antibiotic Community
In the video, Michael Corley, the Head of Policy & Public Affairs at the British […]
NewBiologix Launches with $50M to Advance Novel Technology Platform for the Manufacturing of Gene and Cell Therapies
NewBiologix SA has launched today as a technology innovation company developing a proprietary and breakthrough platform […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more